Related Experiment Video
Updated: May 30, 2026
08:26
Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
A novel bioabsorbable drug-eluting tracheal stent
G H Zhu1, Anthony H C Ng, Subbu S Venkatraman
1Department of Otolaryngology-Head and Neck Surgery, National University of Singapore, Singapore.
The Laryngoscope
|August 9, 2011
Summary
A new bioabsorbable tracheal stent with mitomycin C (MMC) drug elution effectively reduced tracheal stenosis and mucus trapping in rabbits. This innovative stent offers a promising alternative to current treatments for airway obstruction.
Area of Science:
- Biomaterials science
- Regenerative medicine
- Drug delivery systems
Background:
- Current tracheal stents (silicone, metallic) cause complications like granulation, mucus buildup, and difficult removal.
- Tracheal stenosis remains a significant clinical challenge requiring improved therapeutic strategies.
Purpose of the Study:
- To develop and evaluate a novel bioabsorbable tracheal stent.
- To incorporate mitomycin C (MMC) drug elution for enhanced efficacy.
- To mitigate issues associated with conventional tracheal stents.
Main Methods:
- A randomized animal study involving 25 rabbits across five groups.
- Evaluation of control, silicone, bioabsorbable helical, bioabsorbable tubular, and MMC-eluting bioabsorbable tubular stents.
- 12 weeks of weekly tracheal endoscopy and histological analysis, alongside in vitro drug release studies.
Main Results:
- Bioabsorbable tubular stents with 0.1 mg MMC demonstrated superior performance, minimizing mucus trapping and airway obstruction.
- Significant tracheal stenosis was observed in helical stents, followed by controls, non-eluting tubular stents, and silicone stents.
- MMC-eluting bioabsorbable tubular stents reduced tracheal stenosis by 50% compared to silicone stents after 12 weeks.
Conclusions:
- A novel bioabsorbable tracheal stent with sustained MMC drug elution was successfully developed.
- This innovative stent shows potential for preventing tracheal stenosis.
- Further research is needed to optimize stent design and MMC dosage for clinical application.
Related Concept Videos
01:21Tracheostomy Decannulation
Tracheostomy decannulation is a significant milestone in the liberation of mechanically ventilated patients. Despite its importance, there is no universally accepted protocol for this procedure. This demands an evidence-based, individualized approach.
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
01:16Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...